OREX


That’s No Fun: Orexigen Therapeutics, Inc. (OREX) Stock Crashes on Back of Chapter 11 Bankruptcy

It’s a short and dramatic plunge for Orexigen Therapeutics, Inc. (NASDAQ:OREX).

Biotech Stock News: Orexigen Therapeutics, Inc. (OREX), Vertex Pharmaceuticals Incorporated (VRTX), Puma Biotechnology Inc (PBYI)

Orexigen Therapeutics, Inc. (NASDAQ:OREX) On May 12, 2015 Shares of Orexigen tanked by 13% after the company reported that the cardiovascular outcome study had …

Biotech Stock Updates and More

NASDAQ: CHRS– We recommended investors buy Coherus a few weeks ago under the IPO price when it was trading around $13.10.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts